Description
A GCGR antagonist (Ki = 14 nM for the human recombinant receptor); greater than 230-fold selective for GCGR over the GLP-1 receptor, as well as a panel of 69 receptors, ion channels, uptake sites, and enzymes at 10 µM; prevents glucagon-induced increases in glucose levels in rat blood at 7.5 and 75 mg/kg,,
Formal name: N-[4-[(1S)-1-[3,5-dimethyl-4-[4-(trifluoromethyl)-1H-pyrazol-1-yl]phenoxy]butyl]benzoyl]-β-alanine
Synonyms: GCGR Antagonist IV
Molecular weight: 503.5
CAS: 1393124-08-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Endocrinology & Metabolism|Carbohydrate Metabolism||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes